H-NMR Spectroscopy turned out to be the most adequate technique for the detection of the D 2 -olefin 6, as well as of its precursors, and the 2D-COSY experiment allowed us to unequivocally identify the precursor 10 of the D 3,5 -diene 12.
The classical synthesis, followed by purification of the steroidal A-ring D 1 -olefin, 5a-androst-1-en-17one (5) , from the D 1 -3-keto enone, (5a,17b)-3-oxo-5-androst-1-en-17-yl acetate (1) , through a strategy involving the reaction of D 1 -3-hydroxy allylic alcohol, 3b-hydroxy-5a-androst-1-en-17b-yl acetate (2) , with SOCl 2 , was revisited in order to prepare and biologically evaluate 5 as aromatase inhibitor for breast cancer treatment. Surprisingly, the followed strategy also afforded the isomeric D 2 -olefin 6 as a byproduct, which could only be detected on the basis of NMR analysis. Optimization of the purification and detection procedures allowed us to reach 96% purity required for biological assays of compound 5. The same synthetic strategy was applied, using the D 4 -3-keto enone, 3-oxoandrost-4-en-17b-yl acetate (8) , as starting material, to prepare the potent aromatase inhibitor D 4 -olefin, androst-4-en-17-one (15) . Unexpectedly, a different aromatase inhibitor, the D 3,5 -diene, androst-3,5-dien-17-one (12) , was formed. To overcome this drawback, another strategy was developed for the preparation of 15 from 8. The data now presented show the unequal reactivity of the two steroidal A-ring D 1 -and D 4 -3-hydroxy allylic alcohol intermediates, 3b-hydroxy-5a-androst-1-en-17b-yl acetate (2) and 3b-hydroxyandrost-4-en-17byl acetate (9) , towards SOCl 2 , and provides a new strategy for the preparation of the aromatase inhibitor 12. Additionally, a new pathway to prepare compound 15 was achieved, which avoids the formation of undesirable by-products.
Introduction. -Among several biological activities, steroidal A-ring olefins, with a C(17)¼O group, particularly D 3 -and D 4 -olefins ( Fig.) [1] [2] , were shown to be interesting aromatase inhibitors (AIs). AIs block the biosynthesis of estrogens and offer a therapeutic alternative for the treatment of estrogen-dependent cancers, namely breast cancer [3 -5] . This has been attributed to two different factors: the planarity conferred by the C¼C bonds, which allows better fitting the enzyme receptor core, and the H-bonding capacity of the C(17)¼O O-atom to a receptor residue [1] [6] [7] .
As part of a project on new structureÀactivity relationships (SAR) of steroidal AIs [1] [6] [7] , we are now interested in synthesizing D 1 -and D 4 -olefins 5 and 15, respectively (Schemes 1, 2, and 3). Concerning 5, there are very few references describing its preparation, and the most complete one is a 50 years old reporting the synthesis using the D 1 -3-keto enone 1 as starting material, and the allylic alcohol 2 as intermediate [8] . In a recent work, we revisited this synthesis [7] and, in the present work, we further explored new insights into the referred strategy. In this study, along with the previously reported D 1 -olefin 5, the D 2 -isomer 6 was identified as a by-product (Scheme 1).
Furthermore, to achieve an alternative synthetic strategy for the preparation of the D 4 -olefin 15 [2] [7] , that avoids the formation of the D 4 -17b-hydroxylated derivative as well as the D 3 -olefin as by-products, we applied the same methodology using the D 4 -3keto enone 8 as starting material. Unexpectedly, in this case, instead of the desired 15, another AI, the D 3,5 -diene 12 [9 -16] , was obtained as the only product (Scheme 2). To overcome this problem, another synthetic strategy, using also 8 as starting material, was developed for the preparation of 15 (Scheme 3). H-NMR analysis, always turned out to be mixtures 3/4 with variable compositions (from 1 : 3 to 9 : 1). Given the impossibility of obtaining the pure compound 3, the next oxidative step was performed with the the 9 : 1 mixture of 3/4 using Jones reagent, which allowed, after a laborious column chromatography purification process of the obtained crude, isolation of the D 1 -olefin 5 in the required purity for further biological studies (96% by LC/MS control) (Scheme 1).
Although the formation of the D 2 -isomer 6 has not been reported before, our results revealed that migration of the C¼C bond from the C(1) to the more stable C(2) occurred to a considerable extent. In fact, the D 1 -and D 2 -isomers 5 and 6, respectively, possessed similar physico-chemical properties, exhibiting the same R f values with several chromatography solvents and similar crystallization conditions. Accordingly, it is very difficult to distinguish the two isomers. Facing these difficulties, the complete diagnosis of the C¼C bond position in this kind of compounds could only be achieved by 1 H-NMR spectroscopy. The D 1 -isomer 5 presents two signals at 5.52 ppm (HÀC(2)) and 5.83 ppm (HÀC(1)) for the olefinic H-atoms, whereas the D 2 -isomer 6 displays only one common typical multiplet around 5.9 ppm for both olefinic H-atoms, allowing the accurate identification of both compounds 5 and 6. Therefore, the NMR analysis appears to be the most adequate technique to disclose the nature of the compounds isolated after column chromatography.
To obtain the D 4 -olefin 15, the above-mentioned synthetic strategy was further applied to the D 4 -3-keto enone 8 (prepared from 7 [7] ) as starting material (Scheme 2). In this case, instead of 15 we obtained the D 3,5 -diene 12. Treatment of 8 with Li(t-BuO) 3 AlH, under the conditions previously described, led to D 4 -3b-hydroxy allylic alcohol 9 with traces of its 3a-isomer. Treatment of this compound with SOCl 2 in benzene, contrarily to what was expected, gave the D 3,5 -diene precursor 10. Then, 10 was treated with LiAlH 4 to afford the D 3,5 -diene derivative 11, which, after oxidation with CrO 3 in pyridine [10] , led to 12. This approach opens a new way to prepare compound 12, which is also an AI [9] .
As the 1 H-NMR did not allow unequivocal elucidation of the position of the diene C¼C bonds in the A/B-ring system, a 2D-COSY analysis of 10 was performed. The most relevant signals in the COSY spectrum were those of the three olefinic H-atoms at 5.9, 5.6, and 5.4 ppm, of the H a ÀC(17) at 4.5 ppm, and of the Me (18) and Me(19) groups at 0.82 and 0.95 ppm, respectively. The H a ÀC(17) correlates with Me(18) ( 3 J) which resonates at 0.82 ppm; therefore, the resonance at 0.95 ppm is due to Me(19) . Focusing on the three olefinic H-atoms, of the D 3,5 -diene isomer 10, the HÀC(4) will correlate strongly with the HÀC(3) and weakly with the HÀC(6). In fact, we observed that an olefinic H-atom absorbing at 5.9 ppm strongly correlates with an olefinic H-atom at 5.6 ppm ( 3 J); the same olefinic H-atom (at 5.9 ppm) has a very weak correlation with an olefinic H-atom absorbing at 5.4 ppm ( 4 J), and there is no observable correlation between the olefinic H-atom signals at 5.6 ppm and 5.4 ppm ( 5 J). Therefore, the signal at 5.6 ppm corresponds to HÀC(3), the signal at 5.9 ppm to HÀC(4), and the signal at 5.4 ppm to HÀC (6) , which is in agreement with the structure of compound 10.
To obtain the D 4 -olefin 15, an alternative synthetic strategy was developed from the same starting material 8 (Scheme 3). In this case, reaction of 8 with a mixture of NaBH 4 in CF 3 COOH (TFA), glacial AcOH, and MeCN was performed in a controlled environment [17] , to yield compound 13 in 99% yield. This compound was then submitted to a base-catalyzed hydrolysis to give quantitatively compound 14, which was then subjected to Jones oxidation to furnish the desired 15 in 75% yield. The abovementioned strategy avoided the formation of the D 4 -17b-hydroxylated derivative as well as the D 3 -olefin isomer as by-products.
In summary, the preparation of D 1 -olefin 5 from the D 1 -3-keto enone 1 according to the revisited protocol takes place with the formation of the D 2 -isomer 6 as a by-product, which can only be detected by NMR analysis. However, an adequate sequential purification procedure by column chromatography, assisted by 1 H-NMR control of the separated fractions, allows the isolation of the AI 5 in 96% purity, which is an adequate purity for compounds to proceed to biochemical assays.
The potent AI D 4 -olefin 15 cannot be obtained from the D 4 -3-keto enone 8 by the reported strategy. Instead, another important aromatase inhibitor, the D 3,5 -diene 12, is formed. This achievement offers a new synthetic way to compound 12. From these data, presented for the first time, to the best of our knowledge, it is possible to establish the unequal reactivity of steroidal D 1 -and D 4 -3-hydroxy allylic alcohol intermediates 2 and 9, respectively, towards the elimination reactions by treatment with SOCl 2 (Schemes 1 and 2). Indeed, while the D 1 -isomer 2 renders the mixture of olefins 3/4 by the expected elimination process, followed by isomerization of the C¼C bond, the D 4 -isomer 9 embarks in an additional elimination of a HÀC(6) H-atom, followed by the migration of the C¼C bond with the formation of the D 3,5 -diene derivative 10.
The preparation of the AI 15 can be achieved by a new method, using also the D 4 -3keto enone 8 as starting material, by a sequence involving the reduction at C(3), followed by the hydrolysis of the AcO group at C(17) of 13, and subsequent oxidation of the resulting OH group, which precludes the formation of undesirable by-products.
Experimental Part
General. Testosterone (7) was purchased from Pharmacia & Upjohn Company, Kalamazoo, Michigan (USA), and (5a,17b)-3-oxoandrost-1-en-17-yl acetate (1) and (5a)-androst-2-en-17-one (6) were purchased from Steraloids, Inc. (Newport RI, USA). Other reagents and solvents were used as obtained from the suppliers without further purification, with the exception of CH 2 Cl 2 , which was dried through reflux and distilled from CaH 2 [18] . M.p.: Reichert Thermopan hot-block apparatus; uncorrected. IR Spectra: Jasco 420FT/IR spectrometer. 1 H-and 13 C-NMR spectra: Varian 600 MHz spectrometer, using a 3-mm broadband NMR probe; chemical shifts in ppm downfield from TMS used as an internal standard; all J values in Hz. ESI-and LC-MS: mass spectrometer QIT-MS Thermo Finningan, model LCQ Advantage MAX, coupled to a liquid chromatograph of high performance Thermo Finningan (column: C18; reversed phase (RP); H 2 O/MeCN 40 : 60).
(3b,5a,17b)-3-Hydroxyandrost-1-en-17-yl Acetate (2) . See [7] .
(5a,17b)-Androst-1-en-17-ol (3) and (5a,17b)-Androst-2-en-17-ol (4). Prepared as described in [7] . 1 H-NMR Analysis of the obtained crude product revealed a mixture 3/4 1 : 1. The crude product was purified by column chromatography (CC) (neutral Al 2 O 3 ; hexane/CH 2 Cl 2 80 : 20) to give a white solid (one TLC spot). 1 H-NMR Analysis of this solid indicated an enriched mixture of 3 (90%) with 4 (10%).
Data of 3. 1 H-NMR ((D 6 )DMSO; selected signals): see [7] . Data of 4. 1 H-NMR ((D 6 )DMSO; selected signals): 0.63 (s, Me(18)); 0.71 (s, Me (19) ); 3.42 (ddd, J(17a,16a) ¼ 9.0, J(17a,16b) ¼ 9.0, J(17a,OH) ¼ 5.0, H a ÀC(17)); 4.42 (d, J(OH,17a) ¼ 5.0, HO b ÀC(17)); 5.53 -5.59 (m, HÀC(2), HÀC (3)).
(5a)-Androst-1-en-17-one (5) and (5a)-Androst-2-en-17-one (6). Prepared as described in [7] . The obtained crude product was crystallized from MeOH/H 2 O to give white crystals (one TLC spot). 1 H-NMR Analysis of these crystals revealed the presence of a mixture 5 (83%)/6 (17%). Purification by CC (hexane/Et 2 O), followed by consecutive recrystallizations from MeOH, gave 5 in 96% purity (LC/ MS analysis) with a small amount of isomer 6.
Data of 5. 1 H-NMR (CDCl 3 ): see [7] . Data of 6. 1 H-NMR (CDCl 3 ; selected signals): 0.78 (s, Me (19)); 0.87 (s, Me(18)); 5.55 -5.62 (m, HÀC(2), HÀC (3)).
(17b)-3-Oxoandrost-4-en-17-yl Acetate (8) . To a soln. of 7 (2.0 g, 6.93 mmol) in dry pyridine (48 ml), Ac 2 O (7.9 ml, 83.9 mmol) was added, and the mixture was stirred for 21 h 25 min at r.t. (208), until all the starting material was consumed (TLC control). Then, CH 2 Cl 2 (250 ml) was added, and the org. layer was washed with 10% NaHCO 3 (4)). 13 (17)); 123.9 (C(4)); 170.9 (C(5)); 171.1 (OC¼O); 199.4 (C(3)).
(3b,17b)-3-Hydroxyandrost-4-en-17-yl Acetate (9) . To a soln. of 8 (2.0 g, 6.05 mmol) in anh. THF (75 ml) under N 2 , Li(t-BuO) 3 AlH (2.0 g, 7.86 mmol) was added, and the mixture was heated under reflux for 2 h, then an excess of Li(t-BuO) 3 AlH (500.1 mg, 1.97 mmol) was added. The reaction proceeded until complete transformation of the starting material (3 1 (4)). 13 C(3) ); 81.8 (C(17)); 125.5 (C(4)); 143.9 (C(5)); 170.2 (OC¼O).
(17b)-Androsta-3,5-dien-17-yl Acetate (10) . A soln. of crude 9 (500.4 mg) in benzene (10 ml) was kept at 5 -88 under N 2 , treated with SOCl 2 (0.5 ml, 6.72 mmol), and the mixture was stirred for 2 h 25 min. Then, an excess of SOCl 2 (0.1 ml, 1.38 mmol) was added. The reaction did not proceed to the complete transformation of the starting material (5 1 2 h). Benzene was evaporated under vacuum at r.t. giving an oily residue, to which solid NaHCO 3 (500 mg) was added, followed by 10% NaHCO 3 (100 ml). The aq. layer was extracted with CH 2 Cl 2 (3 Â 100 ml), and the resulting org. layer was washed with H 2 O (3 Â 100 ml), dried (anh. MgSO 4 ), filtered, and concentrated to dryness to give a white solid residue. This residue was purified by CC (silica gel 60; PE (60 -808)/AcOEt) to afford 263.4 mg of 10 as a white crystalline residue in an overall yield of 56% from 8. Recrystallization from PE 60 -808/AcOEt. M.p. 116 -1198. IR (CHCl 3 ): 3018 (¼CH), 1736 (C¼O ester), 1648 (C¼C), 1244 (CÀO). 1 H-NMR (CDCl 3 ; selected signals): 0.83 (s, Me(18)); 0.96 (s, Me (19)); 2.04 (s, MeCOO); 4.61 (dd, J(17a,16a) ¼ 9.0, J(17a,16b) ¼ 8.0, H a ÀC(17)); 5.37 -5.38 (m, HÀC(6)); 5.58 -5.60 (m, HÀC(3)); 5.91 -5.93 (m, HÀC(4)). 13 C-NMR (150 MHz, CDCl 3 ): 12.0 (C(18)); 18.8 (C(19)); 20.4; 21.2; 22.9; 23.5; 27.5; 31.3; 31.6; 33.7; 35.2; 36.8; 42.5; 48.3; 51.2; 82.8 (C(17)); 122.6 (C(6)); 125.1 (C(3)); 128.8 (C(4)); 141.5 (C(5)); 171.2 (OC¼O). ESI-MS: 315.1 (76, [M þ H] þ ).
(17b)-Androsta-3,5-dien-17-ol (11). To a soln. of 10 (100.8 mg, 0.32 mmol) in Et 2 O (15 ml), LiAlH 4 (76.2 mg, 2.01 mmol) was added cautiously under N 2 , and the mixture was heated under reflux for 8 h. Then, a sat. soln. of sodium potassium tartrate (150 ml) was added, and the mixture was extracted with Et 2 O (4 Â 100 ml). The org. layer was then washed with H 2 O (4 Â 100 ml), dried (anh. MgSO 4 ), filtered, and concentrated to dryness to give pure 11 (79.4 mg, 91%). White solid. Recrystallization from AcOEt/
